Connect Biopharma
CNTB
Connect Biopharma (CNTB) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Oppenheimer | Initiated Coverage | Outperform | $8.00 | Jul 9, 2026 |
| Piper Sandler | Initiated Coverage | Neutral → Overweight | $7.00 | Jun 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Jun 25, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $6.00 | May 26, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $4.00 | May 21, 2026 |
| BTIG | Maintained | Buy | $10.00 | Apr 1, 2026 |
| BTIG | Maintained | Buy | $10.00 | Mar 31, 2026 |
| Lake Street | Initiated Coverage | Buy | $9.00 | Dec 1, 2025 |
| BTIG | Maintained | Buy | $10.00 | Nov 13, 2025 |
| BTIG | Initiated Coverage | Buy | $10.00 | Oct 31, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Aug 13, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 | Jun 12, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Apr 1, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Mar 31, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Sep 6, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Jun 13, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 from $7.00 | Apr 17, 2024 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 | Mar 4, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | $5.00 | Sep 13, 2023 |
Frequently asked questions
What is the latest analyst rating on CNTB?
On Jul 9, 2026, Oppenheimer initiated coverage of Connect Biopharma at Outperform with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.